USPTO serial 79261502
HUGEL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- LAMONT, MIAH ROSENBERG
- Law office
- LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with HUGEL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary preparations for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases, and skin disorders; drugs for medical purposes; adjuvants for medical purposes; biological preparations for medical purposes, namely, pharmaceutical preparations comprising botulinum toxin, fragments of botulinum toxin; pharmaceutical preparations for treating neurological diseases and disorders; pharmaceutical preparations for treating dystonia; pharmaceutical preparations for the treatment of wrinkles; pharmaceutical preparations for the treatment of spasm; pharmaceutical preparations for the treatment of pain; pharmaceutical agents for treating physically caused lesions; pharmaceutical preparations for use in treating urogenital system diseases and conditions; ophthalmic preparations; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for dental purposes; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating skin disorders; microorganisms for medical purposes; cultures of microorganisms for medical or veterinary use; bacteriological preparations for medical and veterinary use; chemical preparations for pharmaceutical purposes, namely, for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases, and skin disorders; botulinum toxin for medical use for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases, and skin disorders; appetite suppressants for medical purposes; medicated lotions for treating dermatological conditions; ointments for pharmaceutical purposes; analgesics; pharmaceutical agents affecting peripheral nervous system; bacterial poisons; vaccines; hyaluronic acid mixed with its derivatives and other polysaccharides, including or not including lidocaine, in ampoule form for medical purposes; pharmaceutical preparations mainly based on hyaluronic acid; medical gels for activation of tissues, namely, medical gels for hypodermic syringes for improving wrinkles; hyaluronic acid preparations for medical purposes, namely, fillers for skin and soft tissue used for skin moisturizing and improving wrinkles; modified hyaluronic acid preparations for medical purposes, namely, fillers for skin and soft tissue used for skin moisturizing and improving wrinkles; injectable dermal fillers; pre-filled syringes for medical purposes, namely, prefilled with pharmaceutical preparations in the nature of hyaluronic acid, modified hyaluronic acid, its derivatives or substances that have a similar effect to hyaluronic acid, for the treatment and management of skin and soft tissue or artificial prostheses | ACTIVE | — |
| 010 | Medical apparatus and instruments; medical apparatus; surgical apparatus and instruments for medical, dental or veterinary use; medical apparatus and instruments for plastic surgery; medical apparatus and instruments for the treatment of skin; sutures; suture for medical purpose; syringes for medical purposes and for injections; medical filler apparatus; medical filler syringes; dermatoplastic instruments; surgical instruments for use in cosmetic surgery and plastic surgery for skin; skin esthetic massaging apparatus; orthopaedic articles; dental apparatus and instruments; gloves for use in hospitals; masks for medical purposes; dermic implants for medical use, intended for filling of wrinkles or increasing volume; syringes for injecting medical substances for the skin, namely, used for the injection of hyaluronic acid for contouring lips and faces, scar correction and wrinkle reduction for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 14, 2025 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Feb 14, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 21, 2021 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 2, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 2, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 12, 2020 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 25, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 25, 2020 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 2, 2020 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 2, 2020 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 6, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 20, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 20, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 27, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 25, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 24, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 23, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 23, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 29, 2019 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jun 20, 2019 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |